Integumen PLC - Commercial & AI partnership with Acumen Software
AIM share code: SKIN
("Integumen" or "Company")
Integumen signs commercial and AI partnership with
First RAWTestTM commercial agreement for wastewater utility and industrial production clients
Integumen's subsidiary Rinocloud today announces that it has entered into a commercial and AI development partnership with
"We are delighted to have entered into this commercial and RAWTestTM AI development partnership with
Joao Zoio, President of
"This is a very exciting commercial and service development opportunity. The immediate capability to future proof our software platform with Rinocloud's marketing and financial data analytics and the ability to integrate real-time RAWTestTM water monitoring AI system into our mobile asset and management software for our existing wastewater utility and industrial production clients across four continents."
Water use in industry:
Industry is one of the main water users in
| || |
+44 (0) 7340 055 648
| || |
+44 (0) 113 370 8974
| || || |
+44 (0) 20 3657 0050
About Integumen: www.integumen.com
Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units:
· Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services. Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.
· Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.
· Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.
· Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.
This information is provided by RNS, the news service of the
Quick facts: Integumen
Market Cap: £10.66 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE